New MAO Inhibitor Rasagiline Approved for Parkinson’s

In July 2006 the FDA approved a new irreversible monoamine oxidase inhibitor, Rasagiline, for the treatment of Parkinson’s disease.  It will be marketed with the trade name of Azilect by Teva Pharmaceuticals Industries, Ltd. It can be used as monotherapy with early Parkinson’s disease as well as combined with levodopa in later stages.  Trials in animal […]

Toppling Television Sets Injure Young Children

Researchers at the University of Texas Southwestern Medical Center at Dallas have reported on a series of children being hurt by falling TV sets in the home.  In one emergency department alone from November 2003 to October 2004, 26 children from 1 to 7 years of age were evaluated for such injuries.  Nine of these required […]